Related references
Note: Only part of the references are listed.Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Aaron Waxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Supplementation with Iron in Pulmonary Arterial Hypertension Two Randomized Crossover Trials
Luke S. G. E. Howard et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial
Peter Santer et al.
BMJ OPEN RESPIRATORY RESEARCH (2020)
Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide
Lauren Rose et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)
Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension A Population-Based Cohort Study in Ontario, Canada
D. Thiwanka Wijeratne et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension A Population-Based Cohort Study in Ontario, Canada
D. Thiwanka Wijeratne et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension
Thomas Sonnweber et al.
PLOS ONE (2018)
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
Annabel H. Nickol et al.
BMJ OPEN (2015)
Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency
Gerrina Ruiter et al.
PULMONARY CIRCULATION (2015)
Iron Deficiency in Patients With Idiopathic Pulmonary Arterial Hypertension
Vanessa P. M. van Empel et al.
HEART LUNG AND CIRCULATION (2014)
Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target
C. J. Rhodes et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Share Paper
